Biomedtech News

Artedrone announces the appointment of Liane Teplitsky as CEO, Dan Raffi and Nnamdi Njoku to its Board of Directors

February 4, 2025

Artedrone, a Truffle Capital’s medtech portfolio company developing an autonomous micro robotic platform to perform and democratize mechanical thrombectomy procedures to treat patients suffering from a stroke, announces the appointment of Liane Teplitsky as CEO and Nnamdi Njoku, Dan Raffi to its Board of Directors.

Artedrone

Autonomous robotic solution to increase the accessibility of mechanical thrombectomy during acute...

ALSO TO BE DISCOVERED

January 30, 2025

Affluent Medical announces 10th successful human implantation of its Artus urinary sphincter, marking completion of the pilot phase

January 24, 2025

Caranx Medical veut exporter son robot chirurgical aux Etats-Unis

January 13, 2025

Caranx Medical announces FDA submission of TAVIPILOT Soft

November 17, 2024

Philippe Pouletty, CEO and co-founder of Truffle Capital, is a guest on Figaro TV

October 23, 2024

CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners

July 17, 2024

New Nature publication confirms CARBIOS’ leadership in enzymatic degradation of plastic

July 12, 2024

Affluent Medical signs agreements for mitral valve technologies with €15M upfront payment

April 16, 2024

SpikImm Announces an Exclusive License with SATT Conectus for the Development of a Prophylactic mAb Against BK Virus

April 16, 2024

Caranx Medical, announced the successful world first robotic assisted heart valve (aortic valve) implantation in an animal

April 4, 2024

Affluent Medical announces coverage initiation of its stock by Gilbert Dupont – Société Générale Group.